###begin article-title 0
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 472 480 448 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 485 492 461 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 738 745 710 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 270 275 <span type="species:ncbi:4932">yeast</span>
The regulation of gene expression by estrogen receptor-alpha (ERalpha) requires the coordinated and temporal recruitment of diverse sets of transcriptional co-regulator complexes, which mediate nucleosome remodelling and histone modification. Using ERalpha as bait in a yeast two-hybrid screen, we have identified a novel ERalpha-interacting protein, ZNF366, which is a potent corepressor of ERalpha activity. The interaction between ZNF366 and ERalpha has been confirmed in vitro and in vivo, and is mediated by the zinc finger domains of the two proteins. Further, we show that ZNF366 acts as a corepressor by interacting with other known ERalpha corepressors, namely RIP140 and CtBP, to inhibit expression of estrogen-responsive genes in vivo. Together, our results indicate that ZNF366 may play an important role in regulating the expression of genes in response to estrogen.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
Estrogens play diverse roles in the body, most notably in the development and maintenance of the female and the male, reproductive systems and secondary sexual characteristics (1). Estrogens also play a central role in promoting breast cancer growth (2), as well as being implicated in uterine and ovarian cancers (3,4), and are also implicated in the physiology of the brain, bone and the cardiovascular system, as evidenced by the increased risk of cardiovascular disease and osteoporosis engendered by the decline in estrogen levels during menopause (1).
###end p 4
###begin p 5
###xml 193 194 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 195 196 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 668 669 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 670 671 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 927 928 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 929 931 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
Estrogen action is mediated by two highly related estrogen receptors (ERalpha and ERbeta), which are members of the ligand-activated nuclear receptor (NR) superfamily of transcription factors (5,6). NRs are characterized by a DNA binding domain (DBD), comprised of two zinc fingers, which mediate receptor dimerization and binding to specific response elements in the promoters of target genes. Binding of the ligand to the ligand binding domain (LBD), located C-terminal to the DBD, results in a conformational change in the LBD and activation of the intrinsic transcription activation function AF2, which facilitates the recruitment of transcriptional coactivators (7,8). Transcription activation requires cooperation of AF2 with a region N-terminal to the DBD that encodes transcription activation function AF1, which is often, as in the case of ERalpha and ERbeta, regulated by phosphorylation at specific serine residues (9-11).
###end p 5
###begin p 6
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1220 1222 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 1226 1228 1226 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
The liganded estrogen receptors regulate gene expression by direct binding to DNA at estrogen response elements in target genes, resulting in the recruitment of diverse transcriptional coregulators, including the SWI-SNF complexes that remodel chromatin to alter nucleosomal organization in an ATP-dependent manner (12), the p160 family of coactivators (SRC1/NCo-A1, TIF-2/GRIP1 and AIB1/pCIP/ACTR/RAC3/TRAM1) and TRAP/DRIP complexes. (13-15). The p160 coactivators facilitate the recruitment of other proteins, including CBP, its homologue p300 and p/CAF, which possess intrinsic histone acetyltransferase activity, as well as histone methyltransferases CARM1 and PRMT1 that methylate arginine residues in histone tails (16,17). The thyroid receptor-associated protein (TRAP) complex, similar to or identical with the vitamin D3 receptor-interacting protein (DRIP) complex, which is also similar in many respects to the Mediator complex acts to bridge RNA polymerase II with basal transcription factors and transcription activators. These and other coregulators are recruited to gene promoters in a sequential/ordered manner, resulting in cycles of chromatin remodelling and modification that facilitate transcription (13,15,18).
###end p 6
###begin p 7
###xml 136 137 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 406 407 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 408 410 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 411 413 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 672 674 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 675 677 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
The ERalpha LBD is composed of 12 alpha-helices packed in three layers, with a central hydrophobic pocket that accommodates the ligand (7). Helix 12, together with helices 3, 4 and 5, form a coactivator-binding groove. Most coactivators recruited by agonist-bound ERalpha contain LXXLL motifs, which form a two-turn amphipathic alpha-helix that fits into the coactivator-binding groove in the ERalpha LBD (8,19-22). In addition to the well-characterized recruitment of coactivators to the LBD/AF2, coactivator interaction with AF1 of estrogen receptors has also been described, the interaction being influenced by the phosphorylation status of the receptor in some cases (23-25).
###end p 7
###begin p 8
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 467 469 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 470 472 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 559 561 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 562 564 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
When unliganded, some DNA-bound NR recruit the corepressors NCoR and SMRT and associated protein complexes implicated in transcriptional repression and histone deacetylation, these complexes being dissociated upon ligand binding (13-15,26). NCoR/SMRT bind to NR through CoRNR boxes, LXXI/HIXXXL/I motifs, that form a more extended alpha-helix than the LXXLL motifs, with helix 12 in the LBD being displaced from the conformation it occupies in the agonist-bound LBD (27,28). NCoR/SMRT is also recruited by antagonist-bound ERalpha to inhibit gene expression (29-31).
###end p 8
###begin p 9
###xml 310 312 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 466 468 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 469 471 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 472 474 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 658 660 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 661 663 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 868 870 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 871 873 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1175 1177 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
In addition to stimulating gene expression, estrogen-bound ER represses the expression of many genes. Indeed, gene profiling studies show that the down-regulation of gene expression is a significant feature of the response to estrogen in the ERalpha-positive, estrogen-responsive MCF7 breast cancer cell line (32). This is likely to involve transcriptional corepressors, such as LCoR and RIP140, which can be recruited to the agonist-bound ERalpha via LXXLL motifs (20,33,34). Repression by LCoR and RIP140 occurs through HDAC-dependent and -independent mechanisms and involves the recruitment of HDACs and the C-terminal binding protein (CtBP) corepressor (34-39). CtBP, originally identified based on its interaction with the C-terminal end of adenovirus E1A via the sequence PLDLS, is highly conserved in higher eukaryotes and plays a critical role in development (40,41). Other transcription factors also interact with CtBP1, and the highly related CtBP2, through PXDLS motifs. Although, the mechanisms by which CtBP acts as a corepressor have not been fully defined, a recent study has identified CtBP complexes that contain HDACs and histone lysine methyltransferases (42).
###end p 9
###begin p 10
###xml 127 129 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
###xml 278 280 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 362 364 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
The ERalpha DBD participates in the recruitment of transcriptional co-regulator proteins. These include the coactivator XBP-1 (43), which modulates ERalpha signalling both in the absence and presence of estrogen, the signal transducer and activator of transcription-5 (STAT 5) (44) and the corepressor TAF-Ib that has been shown to decrease ERalpha acetylation (45). Here, we report that ZNF366, which encodes an evolutionarily conserved zinc finger protein, interacts with the ERalpha DBD. We also show that ZNF366 represses ERalpha activity through association with RIP140, CtBP and histone deacetylases.
###end p 10
###begin title 11
MATERIALS AND METHODS
###end title 11
###begin title 12
Plasmids
###end title 12
###begin p 13
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b49">49</xref>
###xml 216 221 <span type="species:ncbi:4932">yeast</span>
###xml 521 526 <span type="species:ncbi:4932">yeast</span>
The mammalian expression plasmids and reporter genes have previously been described (37,46-49). Site-directed mutagenesis was used to introduce an EcoRI site 5' to the GAL4 translation initiation site in the pBridge yeast expression plasmid (BD Biosciences, UK), enabling cDNA sequences encoding ERalpha and ERalpha-DeltaLBD to be cloned at this position following removal of the GAL4 sequences encoded between the introduced EcoRI site and the multiple cloning site in pBridge. The pACTII-ZNF366 clone isolated from the yeast 2-hybrid screening encodes sequences corresponding to 439-2761 bp of the ZNF366 mRNA sequence with the accession number NM_152625 in the NCBI database (). The full-length ZNF366 open reading frame was reconstituted from the pACTII-ZNF366 clone and IMAGE EST clone 5204702 (accession no. BI770486), to generate pCMVSPORT6-ZNF366 in which ZNF366 is C-terminally FLAG-tagged. ZNF366 deletion and point mutants were generated by site-directed mutagenesis according to manufacturer's protocols (Stratagene, UK).
###end p 13
###begin title 14
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast 2-hybrid screening
###end title 14
###begin p 15
###xml 88 90 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 354 355 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 359 360 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 364 365 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 426 427 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 703 704 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 708 709 668 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 713 714 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 74 79 <span type="species:ncbi:4932">yeast</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 246 251 <span type="species:ncbi:4932">yeast</span>
PL1alpha (MATalpha ura3-Delta1 his3-Delta200 leu2-Delta1 trp1::ERE)1-URA3 yeast strain (50) was transformed with pBridge(Mod)-ERalpha-DeltaLBD, together with a human placental cDNA expression library (BD Biosciences, UK), using the Alkali-Cation yeast transformation kit (BIO 101 systems, UK). Following transformation, the cells were plated on 15 cm trp- leu- ura- plates. Positive clones arising from the screening of 2 x 104 transformants were re-screened and plasmid DNAs were isolated using the lyticase method from BD Biosciences, UK. Plasmids from positive clones were re-transformed, together with pBridge(Mod)-ERalpha-DeltaLBD or pBridge(Mod)-ERalpha and interactions confirmed by growth on trp- leu- ura- plates.
###end p 15
###begin title 16
Northern blotting
###end title 16
###begin p 17
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b51">51</xref>
Multiple tissue northern blots MTN I and MTN II (BD Biosciences, Europe) were probed following 32P-labelling of the ZNF366 cDNA isolated from the pACTII-ZNF366 clone, as described (51).
###end p 17
###begin title 18
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
Protein expression, purification and glutathione S-transferase (GST)-based interaction assay
###end title 18
###begin p 19
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 124 126 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 180 196 180 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 662 670 659 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 61 67 <span type="species:ncbi:9986">rabbit</span>
###xml 180 196 <span type="species:ncbi:562">Escherichia coli</span>
In vitro transcription/translations were performed using TNT rabbit reticulocyte lysates (Promega, UK), in the presence of [35S]-labelled methionine. GST proteins were induced and Escherichia coli lysates prepared as described previously (33). For pulldowns, GST fusion proteins were purified by affinity chromatography on glutathione-agarose beads and retained as 50% slurry in 20 mM HEPES (pH 7.6), 100 mM KCl, 1 mM EDTA, 1 mM DTT, 20% glycerol, supplemented with protease inhibitors. A total of 100 mul volumes of glutathione-agarose bead slurry loaded with 10 mug of GST fusion proteins were then used directly in binding assays with 10 mul of radiolabelled in vitro translation reactions and 890 mul of low salt buffer [50 mM HEPES (pH 7.6), 250 mM NaCl, 0.5% NP-40, 5 mM EDTA, 0.1% BSA, 0.5 mM DTT, 0.005% SDS and protease inhibitors]. Following 1 h incubation at room temperature, the beads were washed twice with low salt buffer and twice with high-salt buffer (low salt buffer, but with 1 M NaCl). Samples were boiled for 10 min in 80 mul of Laemmli buffer and fractionated by SDS-PAGE. Gels were dried and autoradiographed.
###end p 19
###begin title 20
Reporter gene assays
###end title 20
###begin p 21
###xml 64 68 <span type="species:ncbi:9913">calf</span>
COS-1 cells were maintained in DMEM, supplemented with 5% fetal calf serum (FCS). For transient transfection, cells were seeded in 24-well plates in DMEM lacking phenol red and supplemented with 5% dextran-coated charcoal-stripped FCS (DSS). Following seeding for 24 h, the cells were transfected using Fugene 6 (Roche Diagnostics, UK), with 100 ng of luciferase reporter gene and amounts of expression plasmids as indicated in the figure legends. E2 (10 nM), 4-hydroxytamoxifen (OHT; 100 nM) or ICI 182, 780 (ICI; 100 nM) were added as appropriate. Since the ligands were prepared in ethanol, an equal volume of ethanol was added to the no ligand controls. Luciferase activities were determined using the Dual-Glo Luciferase Assay kit (Promega, UK). For the other reporter gene assays, cells were maintained in DMEM, supplemented with 5% FCS and transfections carried out as above.
###end p 21
###begin title 22
Immunoprecipitations and immunoblotting
###end title 22
###begin p 23
###xml 491 496 <span type="species:ncbi:10090">mouse</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 715 726 <span type="species:ncbi:3704">horseradish</span>
###xml 810 816 <span type="species:ncbi:9986">rabbit</span>
###xml 931 936 <span type="species:ncbi:10090">mouse</span>
###xml 1012 1018 <span type="species:ncbi:9986">rabbit</span>
COS-1 cells were plated in 9 cm dishes in DMEM supplemented with 5% FCS 16 to 24 h prior to transfection. The cells were transfected with 5 mug of the ZNF366-FLAG and ERalpha expression plasmids using Lipofectamine 2000 (Invitrogen, UK). Following transfection for 48 h, the cells were lysed in RIPA buffer [150 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, 0.1% SDS and 50 mM Tris-HCl (pH 7.5)] containing protease inhibitors. Lysates (2 mg) were immunoprecipitated (IP) using the M2 anti-FLAG mouse monoclonal antibody (Sigma-Aldrich, UK), or using an anti-ERalpha antibody (6F11; Novocastra, UK). Control IPs was carried out using mouse IgG (Sigma-Aldrich, UK). IPs were resolved by SDS-PAGE and immunoblotted using horseradish peroxidase (HRP)-labelled HA antibody (Sigma-Aldrich, UK) or using an anti-ERalpha rabbit polyclonal antibody HC20 (Santa Cruz, UK). Co-IP of ZNF366-FLAG with CtBP was carried out as above, except that a mouse monoclonal CtBP antibody (sc-17759; Santa Cruz) was used for the IPs and a rabbit polyclonal CtBP antibody (sc-11390; Santa Cruz) was used for immunoblotting.
###end p 23
###begin p 24
MCF7 cells cultured for 3 days in DMEM lacking phenol red and supplemented with 5% DSS, were transfected with 1 mug of ZNF366-FLAG or vector control, using Fugene 6. The media were replaced with media containing E2 (10 nM) or vehicle, 24 h following transfection and the cells were harvested after a further 24 h. Immunoblotting was performed using antibodies for cathepsin D (ab6313; Abcam, UK), progesterone receptor (SC538; Santa Cruz Biotechnologies, UK), FLAG-M2 and beta-actin (ab6276; Abcam, UK).
###end p 24
###begin title 25
Immunofluorescence
###end title 25
###begin p 26
###xml 204 206 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 848 854 <span type="species:ncbi:9986">rabbit</span>
###xml 1009 1013 <span type="species:ncbi:9925">goat</span>
###xml 1019 1024 <span type="species:ncbi:10090">mouse</span>
###xml 1069 1073 <span type="species:ncbi:9925">goat</span>
###xml 1079 1085 <span type="species:ncbi:9986">rabbit</span>
COS-1 cells plated on glass coverslips placed in 24-well plates in DMEM lacking phenol red and containing 5% DSS, were transiently transfected with 50 ng of ZNF366-FLAG and/or [ERalpha-DeltaNLS (HE257G; (48)] using Fugene 6. Five hours following transfection, culture media were replaced by fresh media containing E2 (100 nM), OHT (1 muM) or ICI 182, 780 (100 nM), or an equal volume of vehicle (ethanol), as appropriate. 24 h later, cells were fixed by the addition of 4% formaldehyde for 10 min at room temperature, washed with phosphate-buffered saline (PBS) and 0.1 M glycine was added for 10 min to neutralize the formaldehyde. Following further washing with PBS, the cells were permeabilized in 1% Triton/PBS for 5 min. After washing with PBS, the cells were incubated at 37degreesC for 1 h with the 6F11 ERalpha antibody (1:50 dilution) and rabbit polyclonal FLAG antiserum (Santa Cruz Biotechnology, UK) (1:350 dilution). The cells were washed and incubated for 1 h at 37degreesC with Alexa Fluor 488 goat anti-mouse immunoglobulins (green) and Alexa Fluor 594 goat anti-rabbit immunoglobulins (red) (1:3000 dilution). The coverslips were mounted on microscope slides using mountant containing Dapi (Vector Laboratories, UK) and immunofluorescence observed using a Zeiss LSM510 confocal microscope.
###end p 26
###begin title 27
Growth assays
###end title 27
###begin p 28
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
MCF7 and MDA-MB-231 cells (2 x 105 cells per well) were seeded in 6-well plates in DMEM lacking phenol red and containing 5% DSS. After 48 h the cells were transfected with 1 mug of ZNF366 or empty vector using Fugene 6. E2 (10 nM) was added after 24 h and cell numbers determined using a haemocytometer after a further 48 h.
###end p 28
###begin title 29
RNA interference and RT-PCR analysis of gene expression
###end title 29
###begin p 30
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
PE04 cells (2.5 x 105 cells) seeded in 6-well plates in RPMI lacking phenol red and containing 5% DSS, were transfected with double-stranded RNA oligonucleotides for ZNF366, lamin A/C or a non-targeting siRNA (Ambion, UK), in serum-free DMEM lacking phenol red, using Oligofectamine (Invitrogen, UK), according to manufacturer's protocols. After 4 h the medium was changed to DMEM lacking phenol red, supplemented with 5% DSS and containing E2 (10 nM), as appropriate. RNA was prepared after a further 24 h and RT-PCR carried out using primers with the sequences: 5'-GGACCAGCTTCAGTCACCTTTCCAGTGGTGGCC-3' and 5'-GGGAGTAAAGCTGGTGCCTGGGGCACAGGTCACG-3' (GREB1), 5'-CCCCATCCAGTACAACTGCT-3' and 5'-CTTCACGTCAGAGTGGACGA-3' (ZNF366), 5'-GCGTACGGCTCTCATCAACT-3' and 5'-GACACTGGAGGCAGAAGAGC-3' (Lamin A/C) and 5'-TCCCATCACCATCTTCCA-3' and 5'-CATCACGCCACAGTTTCC-3' (GAPDH).
###end p 30
###begin title 31
RESULTS
###end title 31
###begin title 32
Identification of ZNF366
###end title 32
###begin p 33
###xml 89 91 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b50">50</xref>
###xml 267 268 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 903 912 887 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 1030 1035 1014 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1038 1040 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 12 17 <span type="species:ncbi:4932">yeast</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
###xml 464 469 <span type="species:ncbi:9606">Human</span>
###xml 569 574 <span type="species:ncbi:9606">human</span>
###xml 614 619 <span type="species:ncbi:4932">yeast</span>
We utilized yeast strain PL1alpha, encoding an integrated estrogen-responsive URA3 gene (50), for screening of a human placental cDNA expression library for proteins that interact with an ERalpha deletion mutant lacking the LBD (ERalpha-DeltaLBD). Screening of 2 x 104 transformants yielded 24 positive clones. One of these encoded the C-terminal portion of ZNF366, described previously based on gene prediction of genomic DNA sequence of human chromosome 5q13.2. Human ESTs were identified using the NCBI site () by carrying out a BLAST search against the database of human ESTs, using sequences derived from the yeast 2-hybrid clone. The exact intron/exon structure of ZNF366 was established by complete DNA sequencing of overlapping EST IMAGE clones with GenBank accession nos BI523869, 5201353, BI770486 and BE552137 to generate an mRNA sequence encoding a predicted polypeptide of 744 amino acids (Figure 1A), encoded within 5 exons. Based on the homology with the Fugu fZF1 gene, this was subsequently confirmed by Gilligan et al. (52).
###end p 33
###begin p 34
###xml 67 85 67 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 217 226 217 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 863 870 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b52">52</xref>
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
###xml 45 48 <span type="species:ncbi:10116">rat</span>
###xml 50 53 <span type="species:ncbi:9615">dog</span>
###xml 55 62 <span type="species:ncbi:9031">chicken</span>
###xml 67 85 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
###xml 574 579 <span type="species:ncbi:9606">human</span>
###xml 695 700 <span type="species:ncbi:9606">human</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
###xml 852 859 <span type="species:ncbi:9031">chicken</span>
###xml 929 934 <span type="species:ncbi:9606">human</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1033 1038 <span type="species:ncbi:9606">human</span>
###xml 1362 1367 <span type="species:ncbi:9606">human</span>
Homology searches identified genes in mouse, rat, dog, chicken and Xenopus tropicalis, having very high amino acid sequence homology (93% or greater) in the zinc finger region and all of which encode 11 zinc fingers (Figure 1B). Regions N- and C-terminal to the zinc fingers were also well conserved, albeit less so than the zinc finger region. Together, the high degree of sequence conservation indicates that the identified vertebrate genes represent orthologues of human ZNF366. Support for this idea is provided by additional homology searches, which indicated that the human gene most closely related to ZNF366 is ZNF710, also encoding an 11 zinc finger protein, the zinc finger regions of human ZNF366 and ZNF710 showing amino acid sequence identity of 78%, considerably lower than the identity between human and the putative ZNF366 homologue in chicken or Xenopus. Moreover, no significant homology was detectable between human ZNF366 and ZNF710 outside the zinc finger region. All other human genes demonstrating homology to human ZNF366 displayed amino acid sequence identities no better than 39%, when the zinc finger region of ZNF366 was used in the BLAST searching. Together with the previous report demonstrating, based on very high (88%) amino acid sequence homology in the zinc finger region, as well as conservation of the chromosome location of human ZNF366 and the Fugu fZF1 gene (52), these analyses indicate that ZNF366 is highly conserved in vertebrate evolution.
###end p 34
###begin p 35
###xml 254 263 254 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1C</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
Northern blotting of human tissue RNAs demonstrated that ZNF366 is broadly expressed at varying levels in human adult tissues, with highest expression in heart, placenta, muscle and spleen, with possible alternative splice forms in the liver and muscle (Figure 1C).
###end p 35
###begin title 36
Interaction of ZNF366 with ER-alpha
###end title 36
###begin p 37
###xml 338 347 322 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 406 415 386 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 462 469 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 258 264 <span type="species:ncbi:9986">rabbit</span>
To further confirm interaction between ERalpha and ZNF366, whole cell lysates were prepared from COS-1 cells transiently transfected with ERalpha and FLAG-tagged ZNF366, in the presence of E2. IP with FLAG antibody, followed by immunoblotting using the HC20 rabbit polyclonal ERalpha antiserum, showed that ERalpha interacts with ZNF366 (Figure 2A), whilst IP of ERalpha co-immunoprecipitated ZNF366-FLAG (Figure 2B), indicating that ERalpha and ZNF366 interact in vivo.
###end p 37
###begin p 38
###xml 143 152 131 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
As expected, PL1alpha cells co-transformed with pBridge(Mod)-ERalpha-DeltaLBD and pACTII-ZNF366 grew on minimal medium lacking lacking uracil (Figure 2C). However, for full-length ERalpha, productive interaction, as assayed by growth in the absence of uracil, was ligand-dependent, requiring the addition of estrogen (17beta-estradiol; E2) or an anti-estrogen 4-hydroxytamoxifen (OHT).
###end p 38
###begin p 39
###xml 201 203 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b48">48</xref>
###xml 259 268 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2D</xref>
###xml 803 810 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 872 879 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 837 842 <span type="species:ncbi:4932">yeast</span>
In order to confirm the ligand requirement for the interaction between ERalpha and/or ZNF366 in mammalian cells, COS-1 cells were transfected with ERalpha-DeltaNLS, which is excluded from the nucleus (48). ZNF366-FLAG was exclusively localized to the nuclei (Figure 2D), whilst ERalpha-DeltaNLS was always cytoplasmic in the presence of E2, or in the presence of the anti-estrogens OHT or ICI 182, 780 (ICI), as well as in the absence of ligand, when expressed alone (data not shown). In cells co-transfected with ZNF366-FLAG and ERalpha-DeltaNLS, ERalpha-DeltaNLS re-localized to the nucleus when E2, OHT or ICI were present, but not in the absence of ligand, indicative of ligand-dependent interaction between the two proteins. These data further demonstrate that ERalpha-DeltaNLS and ZNF366 interact in vivo and in agreement with the yeast 2-hybrid data, show that the in vivo interaction requires estrogen agonist or antagonist binding by ERalpha.
###end p 39
###begin p 40
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 234 243 230 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 312 319 304 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 508 510 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b53">53</xref>
###xml 651 653 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b54">54</xref>
In contrast, in vitro binding assays showed that ERalpha bound to GST-ZNF366 in the absence of ligand, as well as in the presence of E2 or anti-estrogens, although the interaction appeared to be greater in the presence of E2 and ICI (Figure 3C), which may suggest that the interaction between ERalpha and ZNF366 in vivo is regulated by other factors (see Discussion). ERalpha can be phosphorylated at serine 118 within AF1, and substitution of this residue by alanine significantly reduces ERalpha activity (53). Substitution of leucine-539 and leucine-540 in the LBD also dramatically reduces ERalpha activity, by preventing coactivator recruitment (54). Substitution of serine 118 or of leucine-539/540 did not inhibit ZNF366 interaction with ERalpha, suggesting that AF1 and the LBD/AF2 may not be involved in the interaction of ZNF366 with ERalpha.
###end p 40
###begin p 41
###xml 251 260 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D</xref>
GST pulldowns were performed to delineate the regions of ERalpha and ZNF366 required for their interaction. ERalpha deletion mutants lacking AF1 (ERalpha-DeltaAF1) or the LBD (ERalpha-DeltaLBD) interacted with ZNF366, as did the isolated ERalpha DBD (Figure 3D), whereas the interaction with the LBD was weak, suggesting that the ERalpha DBD is required for interaction with ZNF366. GST fusion proteins encoding the N- and C-terminal regions of ZNF366, ZNF366(9-251) and ZNF366(558-744) respectively, did not interact with ERalpha, indicating that the zinc finger region is required for the interaction. Interestingly, this assay suggests that the interaction requires independent binding to several zinc fingers, since ZNF366(9-452) and ZNF366(455-744), which do not overlap, both interacted with ERalpha.
###end p 41
###begin title 42
ZNF366 is a corepressor for ERalpha
###end title 42
###begin p 43
###xml 131 140 127 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 183 192 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 221 230 201 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 631 640 607 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D</xref>
###xml 795 797 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
In reporter gene assays, co-transfection with increasing amounts of ZNF366 showed a dose-dependent inhibition of ERalpha activity (Figure 4A). ZNF366 repressed AF1 (ERalpha-DeltaLBD; Figure 4B) and AF2 (ERalpha-DeltaAF1; Figure 4C), in agreement with the GST pulldowns that indicate interaction of ZNF366 with the ERalpha DBD. A trans-repression assay was employed to see whether ZNF366 is a repressor and encodes autonomous repression domain(s). For this, a luciferase reporter gene under the control of LexA and Gal4 binding sites upstream of an E1A TATA box was used. As expected, LexA-VP16 stimulated reporter gene expression (Figure 4D), with this activity being reduced in a dose-dependent manner by the Gal4 DBD fused to the NR corepressors RIP140 (Gal4-RIP140), as described previously (37). ZNF366 similarly repressed reporter gene activity in a dose-dependent manner, confirmative of its activity as a transcriptional repressor.
###end p 43
###begin p 44
###xml 246 247 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 261 270 253 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4E</xref>
###xml 541 548 533 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 105 110 <span type="species:ncbi:9606">human</span>
In order to address the potential activity of ZNF366 on ERalpha-regulated gene expression, we looked for human cell lines in which the genes were co-expressed (data not shown). The PE04 ovarian cancer cell line was found to express both ERalpha (3) and ZNF366 (Figure 4E). Transfection with siRNA for ZNF366 resulted in down-regulation of ZNF366 expression and concomitant increase in the expression of the estrogen-responsive GREB1 and TERT genes, indicating that ZNF366 is involved in the regulation of estrogen-responsive gene expression in vivo.
###end p 44
###begin title 45
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
ZNF366 interacts with CtBP in vitro and in vivo
###end title 45
###begin p 46
###xml 214 216 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 289 291 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 380 389 372 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 437 439 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 528 537 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
Since ZNF366 can repress ligand-stimulated ERalpha activity, we wondered whether it interacts with other corepressors that are known to associate with ERalpha in a ligand-dependent manner. Amongst these is RIP140 (33), which acts by recruiting HDACs and C-terminal binding protein (CtBP) (37). In GST pulldown assays, ZNF366 interacted with RIP140 1-415 and 753-1158 amino acids (Figure 5A), which encode repression domains RD1 and RD4 (37). This interaction appeared to require the C-terminal-most zinc fingers 8-11 of ZNF366 (Figure 5B).
###end p 46
###begin p 47
###xml 50 59 50 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 141 150 141 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 707 716 707 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
Interestingly, ZNF366 also interacted with CtBP1 (Figure 5A), the interaction apparently requiring sequences C-terminal to the zinc fingers (Figure 5B). Many proteins interact with CtBP through sequence motifs having the consensus sequence PXDLS, with a lysine residue two amino acids C-terminal to the serine also often being present (41). Two such motifs, 590-PFDLS(QK)-596 and 645-PEDLS(TK)-651 (Figure 1) are located within the region of ZNF366 required for interaction with CtBP. Mutation of the CtBP motifs by substituting the proline (P) and aspartic acid (D) residues by alanines, prevented interaction between ZNF366 and CtBP in GST pulldown assays (Figure 5C) and in a mammalian two-hybrid assay (Figure 5D). Mutation of M1 or the M2 motif reduced the interaction between ZNF366 and CtBP1. In these assays, the N-terminal CtBP motif (M1) appeared to be more important than the C-terminal motif (M2).
###end p 47
###begin p 48
###xml 145 154 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5E</xref>
In the trans-repression assay, mutation of the N-terminal-most CtBP binding motif in ZNF366 (M1) partially relieved the repression of LexA-VP16 (Figure 5E), whereas mutation of the second motif (M2) did not significantly relieve the repression and mutation of both motifs almost completely abolished the repression by ZNF366. These findings show that the interaction between ZNF366 and CtBP is important for the repression activity of ZNF366, the interaction being mediated by two CtBP-interaction motifs, with both motifs being required for the interaction with CtBP, although motif M1 may be more important than M2 for the interaction.
###end p 48
###begin p 49
###xml 178 187 178 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5F</xref>
###xml 270 279 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5G</xref>
###xml 435 443 435 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 448 455 448 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 670 679 666 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
Whole cell lysates prepared from COS-1 cells transiently transfected with CtBP1 and FLAG-tagged ZNF366 immunoprecipitated using a CtBP antibody resulted in co-IP of FLAG-ZNF366 (Figure 5F). In the reciprocal experiment, CtBP1 was co-immunoprecipitated with FLAG-ZNF366 (Figure 5G). CtBP1 was not co-immunoprecipitated with ZNF366 in which the CtBP binding motifs were mutated. Collectively these data demonstrate that ZNF366 interacts in vitro and in vivo with CtBP1, the interaction being mediated by two CtBP binding motifs. In agreement with these findings substitution of the CtBP motifs in ZNF366 significantly reduced the repression of ERalpha activity by ZNF366 (Figure 6A).
###end p 49
###begin p 50
###xml 253 262 249 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 338 347 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6C</xref>
Gene repression by transcriptional corepressors, including RIP140 and CtBP, frequently requires HDAC recruitment and histone deacetylation. The HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) relieved the repression of ERalpha activity by ZNF366 (Figure 6B), whilst GST pulldowns showed that ZNF366 interacts with HDACs 1, 3 and 6 (Figure 6C), indicating that transcriptional repression by ZNF366 is mediated, at least in part through histone deacetylation.
###end p 50
###begin title 51
ZNF366 represses the expression of estrogen-responsive genes in breast cancer cells
###end title 51
###begin p 52
###xml 239 240 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 770 779 754 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 847 856 831 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 982 991 962 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
The majority of breast cancers express ERalpha, and the growth of ERalpha-positive breast tumours is stimulated by estrogen, as evidenced by the utility of anti-estrogens and inhibitors of estrogen biosynthesis in breast cancer treatment (2). The MCF7 breast cancer cell line expresses ERalpha and grows in response to estrogen, its growth being inhibited by anti-estrogens. Further, MCF7 cells demonstrate estrogen-stimulated expression of a number of well-characterized estrogen-responsive genes, including cathepsin D and pS2. In order to evaluate the effect of ZNF366 on ERalpha-regulation of these genomically encoded estrogen-responsive genes, MCF7 cells were transfected with ZNF366. This resulted in a marked reduction in expression of both cathepsin D and pS2 (Figure 7A). MCF7 cell growth was also reduced following ZNF366 transfection (Figure 7B), whilst growth of an ERalpha-negative breast cancer cell line that is not estrogen-responsive, was not inhibited by ZNF366 (Figure 7C).
###end p 52
###begin title 53
DISCUSSION
###end title 53
###begin p 54
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b55">55</xref>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b56">56</xref>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b57">57</xref>
Zinc finger proteins constitute a very large family of transcriptional regulators and can be further subdivided into groupings based on the type of zinc finger present, as well as by the presence of additional motifs elsewhere in the protein that mediate protein-protein interactions and transcriptional regulation. Sequence analysis of ZNF366 shows that it encodes encodes a protein containing 11 Kruppel-type C2H2 zinc fingers, which is highly conserved in vertebrate evolution. However, ZNF366 does not belong to any of the major subfamilies of the Kruppel zinc finger family and shows most significant amino acid sequence similarity to one other Kruppel zinc finger protein, ZNF710, of unknown function, where the homology is restricted to the Kruppel zinc finger region. However, several other Kruppel-type zinc finger proteins act as transcriptional repressors, including ZNF217, a putative oncogene that is amplified and overexpressed in breast and other cancers (55,56), and copurifies with a CtBP corepressor complex (42). Further, the Bcl11 Kruppel zinc finger gene, which is translocated in B-cell chronic lymphocytic leukemias, acts as a corepressor for the COUP-TF NR (57).
###end p 54
###begin p 55
###xml 103 108 <span type="species:ncbi:4932">yeast</span>
Although we did not investigate the potential of ZNF366 to bind DNA, alter reporter gene activities in yeast or in mammalian cells in the absence of ERalpha (see Results and Supplementary Figure 1A). Further, ZNF366 did not bind to estrogen response elements in gelshift assays (Supplementary Figure 1B). Recruitment of ERalpha to the estrogen-responsive pS2 gene promoter was also not inhibited by ZNF366 expression in MCF7 cells (Supplementary Figure 1C). Collectively, these findings indicate that the repression of estrogen-responsive reporter genes by ZNF366 does not involve inhibition of DNA binding by ERalpha.
###end p 55
###begin p 56
###xml 516 524 500 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 609 616 593 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 741 748 721 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1015 1017 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b58">58</xref>
ZNF366 appears to be recruited to estrogen-responsive genes through interaction of the zinc finger region of ZNF366 with the zinc finger region (DBD) of ERalpha. Whilst the zinc finger region was required for ZNF366 interaction with ERalpha, the exact sequence requirements for the interaction with ERalpha were not established, although non-overlapping regions of ZNF366, encoding zinc fingers 1-7 or 8-11 were sufficient for the interaction. Whilst the interaction of ZNF366 and ERalpha did not require ligand for in vitro assays, the interaction was apparently better in the presence of estrogen. Further, in vivo assays demonstrated a requirement for estrogen or anti-estrogen binding for the interaction between ZNF366 and ERalpha. The in vivo requirement for ligand binding may be influenced by post-translational modifications. Additionally, steroid receptors, including ERalpha, are complexed in the unliganded state, with the Hsp90 chaperone complex, required for appropriate folding of steroid receptors (58). The Hsp90-steroid receptor also likely interferes with steroid receptor interaction with some proteins. Ligand binding results in a conformational change in steroid receptors and Hsp90 dissociation. This could explain the estrogen and anti-estrogen regulation of ZNF366 recruitment by ERalpha.
###end p 56
###begin p 57
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro, ZNF366 also interacted with other steroid receptors (ERbeta, androgen and glucocorticoid receptors), as well as the non-steroid retinoic acid, retinoid X and peroxisome proliferators-activated receptors (data not shown). In all cases the ZNF366 zinc finger region mediated the interaction, with no interaction being detected for the region C-terminal to the zinc finger region (558-744 amino acids), with the exception of retinoid X receptor-alpha (RXRalpha). In this case, ligand-stimulated interaction of RXRalpha with 558-744 amino acids was observed, indicating that the interaction between ZNF366 and RXRalpha is mechanistically distinct from the interaction of ZNF366 with other NRs, perhaps requiring the potential LXXLL motif located near the C-terminus of ZNF366.
###end p 57
###begin p 58
###xml 532 540 516 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
ZNF366 inhibited ligand-dependent transactivation by ERalpha in a dose-dependent manner and functioned as a repressor when tethered to DNA by the GAL4 DBD. Its interaction with the ERalpha DBD suggests that the observed repression is not due simply to prevention of coactivator recruitment, nor does ZNF366 inhibit DNA binding by ERalpha (data not shown). Rather, ZNF366 appears to recruit multiple factors that act to repress transcription. Hence, the HDAC inhibitor SAHA partially relieved the repression of ERalpha by ZNF366 and in vitro binding assays showed that ZNF366 interacts with Class I HDACs 1 and 3, as well as the Class II HDAC6, indicating that the corepressor activity of ZNF366 is, at least in part, HDAC-dependent.
###end p 58
###begin p 59
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b59">59</xref>
###xml 254 256 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b60">60</xref>
###xml 433 435 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 436 438 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 439 441 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b61">61</xref>
###xml 598 600 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 759 761 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b62">62</xref>
###xml 918 926 914 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 931 938 927 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Several different corepressor complexes that are associated with NRs have been identified, most notably N-CoR-SMRT complexes that include HDACs (59). These are usually recruited to unliganded or antagonist-bound NRs, such as the tamoxifen-bound ERalpha (60). RIP140 is unusual in being a corepressor that is recruited by agonist-bound NRs. The repressive activity of RIP140 is achieved by the recruitment of class I HDACs and CtBP1 (35-39,61). CtBP1 and the related protein CtBP2 are potent corepressors that are present in protein complexes containing HDACs and histone lysine methyltransferases (42), and its corepressor activity is mediated through HDAC-dependent and-independent mechanisms, the HDAC-independent mechanisms likely involving PcG complexes (62). ZNF366 interacted with RIP140, the interaction requiring 455-558 amino acids of ZNF366, which encode zinc fingers 7-11. ZNF366 also interacted with CtBP1 in vitro and in vivo, the interaction being mediated by two PXDLS CtBP-interaction motifs located C-terminal to the zinc fingers in ZNF366. Mutation of the CtBP-interacting motifs prevented the interaction of ZNF366 and CtBP1 and relieved repression of ERalpha activity by ZNF366, confirming the importance of CtBP recruitment for the corepressor activity of ZNF366. However, the mutant ZNF366 still significantly repressed ERalpha activity, likely due to the fact that it directly interacts with HDACs and with RIP140.
###end p 59
###begin p 60
###xml 738 745 718 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
These studies suggest that ZNF366 acts as a corepressor for ERalpha. In agreement with these findings, transfection of ZNF366 into the estrogen-responsive and ERalpha-positive MCF7 breast cancer cell line, which does not express ZNF366 (data not shown), reduced expression of genomically encoded ERalpha-regulated genes. Moreover, expression of ZNF366 inhibited MCF7 cell growth in response to estrogen, whereas ZNF366 expression did not inhibit growth of the ERalpha-negative, MDA-MB-231 breast cancer cell line that is not estrogen-responsive. Finally, RNAi-mediated down-regulation of ZNF366 in the ERalpha-positive PE04 ovarian cell line, stimulated expression of the estrogen-regulated GREB1 and TERT genes, further evidence for the in vivo role of ZNF366 as a corepressor for ERalpha.
###end p 60
###begin p 61
In summary, we have identified a novel ERalpha-interacting protein ZNF366, which represses ligand-dependent ERalpha transactivation by recruitment of multiple factors, to regulate the expression of estrogen-responsive genes. ZNF366 is widely expressed in adult tissues and our preliminary findings of interaction between ZNF366 and many other NRs suggest that ZNF366 may have a widespread role as a NR corepressor, in addition to its action as an ERalpha corepressor, as defined in this study.
###end p 61
###begin title 62
SUPPLEMENTARY DATA
###end title 62
###begin p 63
Supplementary Data are available at NAR online.
###end p 63
###begin title 64
Supplementary Material
###end title 64
###begin title 65
[Supplementary Data]
###end title 65
###begin p 66
The authors would like to thank Drs P. Chambon, J. H. White, C. Bevan, G. Williams. J. Brosens and B. Gellersen for generous gifts of plasmids. The authors are also extremely grateful to Drs S. P. Langdon and A. Paige for the ovarian cancer cell lines. This work has been made possible by funding generously provided by Cancer Research UK.
###end p 66
###begin p 67
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 67
###begin title 68
REFERENCES
###end title 68
###begin article-title 69
Lessons in estrogen biology from knockout and transgenic animals
###end article-title 69
###begin article-title 70
Endocrine-responsive breast cancer and strategies for combatting resistance
###end article-title 70
###begin article-title 71
Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen
###end article-title 71
###begin article-title 72
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
###end article-title 72
###begin article-title 73
Estrogen receptor action
###end article-title 73
###begin article-title 74
The nuclear receptor superfamily: the second decade
###end article-title 74
###begin article-title 75
Molecular basis of agonism and antagonism in the oestrogen receptor
###end article-title 75
###begin article-title 76
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
###end article-title 76
###begin article-title 77
Estrogen receptor phosphorylation
###end article-title 77
###begin article-title 78
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
###end article-title 78
###begin article-title 79
The nuclear receptor ligand-binding domain: structure and function
###end article-title 79
###begin article-title 80
Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes
###end article-title 80
###begin article-title 81
Combinatorial control of gene expression by nuclear receptors and coregulators
###end article-title 81
###begin article-title 82
Mediator complexes and transcription
###end article-title 82
###begin article-title 83
Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response
###end article-title 83
###begin article-title 84
Regulation of transcription by a protein methyltransferase
###end article-title 84
###begin article-title 85
Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities
###end article-title 85
###begin article-title 86
Transcription in four dimensions: nuclear receptor-directed initiation of gene expression
###end article-title 86
###begin article-title 87
A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors
###end article-title 87
###begin article-title 88
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
###end article-title 88
###begin article-title 89
The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
###end article-title 89
###begin article-title 90
Ligand control of coregulator recruitment to nuclear receptors
###end article-title 90
###begin article-title 91
Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1
###end article-title 91
###begin article-title 92
Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains
###end article-title 92
###begin article-title 93
###xml 134 139 <span type="species:ncbi:9606">human</span>
Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha
###end article-title 93
###begin article-title 94
Corepressors: custom tailoring and alterations while you wait
###end article-title 94
###begin article-title 95
The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
###end article-title 95
###begin article-title 96
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha
###end article-title 96
###begin article-title 97
The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
###end article-title 97
###begin article-title 98
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Recruitment of distinct chromatin-modifying complexes by tamoxifen-complexed estrogen receptor at natural target gene promoters in vivo
###end article-title 98
###begin article-title 99
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Differential SERM effects on corepressor binding dictate ERalpha activity in vivo
###end article-title 99
###begin article-title 100
###xml 64 69 <span type="species:ncbi:9606">human</span>
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype
###end article-title 100
###begin article-title 101
Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
###end article-title 101
###begin article-title 102
Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms
###end article-title 102
###begin article-title 103
Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing
###end article-title 103
###begin article-title 104
Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP
###end article-title 104
###begin article-title 105
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140
###end article-title 105
###begin article-title 106
Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140
###end article-title 106
###begin article-title 107
Characterization of receptor-interacting protein 140 in retinoid receptor activities
###end article-title 107
###begin article-title 108
A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis
###end article-title 108
###begin article-title 109
CtBP, an unconventional transcriptional corepressor in development and oncogenesis
###end article-title 109
###begin article-title 110
Coordinated histone modifications mediated by a CtBP co-repressor complex
###end article-title 110
###begin article-title 111
Ligand-independent activation of estrogen receptor alpha by XBP-1
###end article-title 111
###begin article-title 112
Cross-talk between ERs and signal transducer and activator of transcription 5 is E2 dependent and involves two functionally separate mechanisms
###end article-title 112
###begin article-title 113
A novel estrogen receptor alpha-associated protein, template-activating factor Ibeta, inhibits acetylation and transactivation
###end article-title 113
###begin article-title 114
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human estrogen receptor has two independent nonacidic transcriptional activation functions
###end article-title 114
###begin article-title 115
###xml 11 16 <span type="species:ncbi:9606">human</span>
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
###end article-title 115
###begin article-title 116
Cooperation of proto-signals for nuclear accumulation of estrogen and progesterone receptors
###end article-title 116
###begin article-title 117
T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif
###end article-title 117
###begin article-title 118
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 95 100 <span type="species:ncbi:4932">yeast</span>
Functional analysis of the human estrogen receptor using a phenotypic transactivation assay in yeast
###end article-title 118
###begin article-title 119
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
Fugu and human sequence comparison identifies novel human genes and conserved non-coding sequences
###end article-title 119
###begin article-title 120
###xml 84 89 <span type="species:ncbi:9606">human</span>
Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region
###end article-title 120
###begin article-title 121
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
###end article-title 121
###begin article-title 122
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma
###end article-title 122
###begin article-title 123
The candidate oncogene ZNF217 is frequently amplified in colon cancer
###end article-title 123
###begin article-title 124
###xml 114 121 <span type="species:ncbi:9031">chicken</span>
Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors
###end article-title 124
###begin article-title 125
Chaperoning steroid hormone action
###end article-title 125
###begin article-title 126
The coregulator exchange in transcriptional functions of nuclear receptors
###end article-title 126
###begin article-title 127
Molecular determinants for the tissue specificity of SERMs
###end article-title 127
###begin article-title 128
A regulatory role for RIP140 in nuclear receptor activation
###end article-title 128
###begin article-title 129
Linking the Rb and polycomb pathways
###end article-title 129
###begin title 130
Figures and Tables
###end title 130
###begin p 131
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 390 391 390 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1128 1146 1128 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus tropicalis</italic>
###xml 1257 1258 1257 1258 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
###xml 736 741 <span type="species:ncbi:9606">human</span>
###xml 955 962 <span type="species:ncbi:9031">chicken</span>
###xml 1036 1041 <span type="species:ncbi:9606">human</span>
###xml 1058 1063 <span type="species:ncbi:10090">mouse</span>
###xml 1077 1080 <span type="species:ncbi:10116">rat</span>
###xml 1094 1097 <span type="species:ncbi:9615">dog</span>
###xml 1114 1121 <span type="species:ncbi:9031">chicken</span>
###xml 1128 1146 <span type="species:ncbi:8364">Xenopus tropicalis</span>
The amino acid sequence and tissue distribution of human ZNF366. (A) The deduced amino acid sequence of human ZNF366 is shown in the single letter amino acid code, with the cysteine (C) and histidine (H) residues of the 11 zinc fingers in ZNF366 highlighted, as are the conserved phenylalanine (F) and leucine (L) residues. Potential CtBP binding motifs and an LXXLL motif are underlined. (B) A schematic representation of ZNF366 from different species is shown, together with the position of the zinc fingers and the putative CtBP and LXXLL motifs, the sequences for these motifs in human ZNF366 being shown. The numbers below the representation of ZNF366 from each species refer to percentage amino acid sequence homology relative to human ZNF366. The numbers to the right refer to the predicted number of amino acids encoded by the ZNF366 genes from different species. The region encoding 277-1053 amino acids was used for alignment in the case of the chicken ZNF366. ZNF366 sequences used here have GenBank accession nos NM_152625 (human), NM_001004149 (mouse), XM_226715 (rat), XP_544370 (dog) and XP_429153 (chicken). The Xenopus tropicalis ZNF366 sequence was derived from the ENSEMBL database, from sequences having the Gene ID ENSGALG00000015008. (C) Northern blot of 2 mug of poly(A)+ RNA from the tissues indicated, probed with ZNF366 cDNA. Size markers are shown on the right.
###end p 131
###begin p 132
###xml 37 38 33 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 43 44 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 294 295 282 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 723 724 686 687 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 318 323 <span type="species:ncbi:4932">yeast</span>
###xml 496 501 <span type="species:ncbi:4932">Yeast</span>
Interaction of ZNF366 with ERalpha. (A and B) Lysates prepared from COS-1 cells transiently transfected with ERalpha and ZNF366-FLAG were immunoprecipitated with mouse IgG, or with ERalpha or FLAG antibodies. Input represents 5% of the total volume of lysate used in the immunoprecipitations. (C) Cultures of PL1alpha yeast cells transformed with pBridge(Mod), pBridge(Mod)-ERalpha-DeltaLBD or pBridge(Mod)-ERalpha, together with pACTII or ZNF366 were spotted at various dilutions, as indicated. Yeast growth was performed over 7 days at 30degreesC, in the presence of 17beta-estradiol (E2; 1 nM), 4-hydroxytamoxifen (OHT; 100 nM) or in the absence of ligand (no ligand), on plates lacking tryptophan, leucine and uracil. (D) COS-1 cells transiently transfected with ERalpha-DeltaNLS and/or FLAG-ZNF366 were visualized by immunofluoresecent staining, as described in Materials and Methods. Dapi was used to visualize nuclei. Estrogen (100 nM), OHT or ICI (100 nM) were added as indicated.
###end p 132
###begin p 133
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 51 52 51 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 256 257 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 262 263 258 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 318 320 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 557 565 549 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In vitro interaction between ER and ZNF366. (A and B) Schematic representations of ERalpha, ZNF366 and deletion mutants are shown. All N-terminal ZNF366 fusion proteins started at amino acid 9, thereby avoiding potential internal translation start sites. (C and D) GST binding assays were carried out by incubation of 35S-labelled ERalpha or mutants with GST or GST-ZNF366 fusion proteins, in the absence of ligand (NL) or in the presence of 100 nM E2, OHT or ICI. E2 was present throughout in part (D). Input lanes represent 20% of the total volume of the in vitro translation reaction used in the binding assay.
###end p 133
###begin p 134
###xml 44 45 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 758 759 746 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 764 765 752 753 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 895 896 867 868 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1143 1144 1115 1116 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
ZNF366 is a repressor of ERalpha activity. (A) COS-1 cells were transfected with ERE-3-TATA-luc (100 ng), ERalpha (100 ng), ZNF366 and the RLTK renilla luciferase reporter (100 ng). Results represent the mean of three independent experiments individually corrected for transfection efficiency against renilla luciferase activity. Error bars represent the standard error of the mean. The activity for ERalpha in the presence of E2 and in the absence of ZNF366 was taken as 100%. All other activities are shown relative to this. The amounts of ZNF366 transfected were 0 ng (lanes 1, 7, 13 and 19), 0.1 ng (lanes 2, 8, 14 and 20), 1 ng (lanes 3, 9, 15 and 21), 10 ng (lanes 4, 10, 16 and 22), 30 ng (lanes 5, 11, 17 and 23) or 100 ng (lanes 6, 12, 18 and 24). (B and C) Reporter gene assays were performed following transfection of 100 ng ERalpha-DeltaLBD (B) or ERalpha-DeltaAF1 (C), as for (A). (D) COS-1 cells were co-transfected with 100 ng Gal4 DBD, the Gal4 DBD fused to full-length RIP140 or ZNF366 together with LexA-VP16 and the Lex-Gal-luc reporter gene. Relative reporter gene activities from three independent experiments are shown. (E) Shown are RT-PCR carried out using PCR primers for GREB1, TERT, ZNF366, Lamin A/C and GAPDH, using total RNA prepared from PE04 cells transfected with non-targeting control, Lamin A/C, or ZNF366 siRNA.
###end p 134
###begin p 135
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 204 206 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 231 232 223 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 349 350 341 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 518 519 510 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 866 867 858 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 872 873 864 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1280 1285 <span type="species:ncbi:10090">mouse</span>
ZNF366 interacts with CtBP in vitro and in vivo. RIP140 fragments (A), ZNF366 fragments (B), CtBP1 (A and E) or ERalpha-DeltaLBD (A) fused to GST, were immobilized on glutathione beads and incubated with 35S-labelled ZNF366 (A and C), CtBP1 (A, B) or RIP140 (B). Bound proteins were eluted, resolved by 10% SDS-PAGE and exposed to autoradiography. (D) Mammalian 2-hybrid assay was performed by co-transfecting 100 ng Gal4 DBD or Gal4 fusions with ZNF366 558-744 amino acids, and 100 ng of VP16 or VP16 fused to CtBP. (E) COS-1 cells were co-transfected with LexA-VP16 and the Lex-Gal-luc reporter plasmid, together with the Gal4 DBD or Gal4 fused to 558-744 amino acids of ZNF366 in which the N-terminal (M1), the C-terminal (M2) or both (M1/M2) CtBP binding motifs have been mutated. Relative reporter gene activities from three independent experiments are shown. (F and G) Whole cell lysates prepared from COS-1 cells transiently transfected with CtBP1 and FLAG-tagged ZNF366 or FLAG-tagged ZNF366 mutated in the CtBP binding sites were immunoprecipitated using antibodies to CtBP1, followed by western blotting for CtBP1 and FLAG (F) or using the FLAG antibody followed by western blotting for FLAG and CtBP1 (G). In each case control immunoprecipitations were performed using mouse IgG.
###end p 135
###begin p 136
###xml 58 59 54 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 319 320 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 475 477 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 597 605 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Repression of ERalpha activity by ZNF366 involves HDACs. (A) COS-1 cells were transfected with ERE-3-TATA-luc (100 ng), ERalpha (100 ng) and ZNF366 (10 ng) or ZNF366 in which the CtBP sites have been mutated (ZNF366-Mut). E2 (10 nM) was present throughout. Results represent the mean of three independent experiments. (B) SAHA and E2 were added 24 h following transfection with ERalpha and ZNF366 and cells processed as above. GST pulldowns were carried out by incubation of 35S-labelled HDAC 1, 3, 4 or 6, with GST-ZNF366 fusion proteins. The input lanes represent 20% of the total volume of the in vitro translation reaction used in the binding assay.
###end p 136
###begin p 137
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 346 347 343 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 352 353 349 350 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
ZNF366 acts as a corepressor for endogenous estrogen-responsive genes. (A) MCF7 cells cultured in estrogen-free medium for 3 days were transfected with ZNF366 or control vector. E2 (10 nM) was added 24 h following transfection and lysates prepared after a further 24 h, were immunoblotted for cathepsin D (CTD), pS2, FLAG-ZNF366 and beta-actin. (B and C) MCF7 and MDA-MB-231 cells were transfected as above and cell counts obtained 72 h after the addition of E2. The means of three experiments are shown, error bars representing the standard error of the mean.
###end p 137

